TANG CAPITAL PARTNERS LP 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | TANG CAPITAL PARTNERS LP | 2,204,797 6.700% | 203,212 (+10.15%) | Filing |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | TANG CAPITAL PARTNERS LP | 2,001,585 7.500% | -90,168 (-4.31%) | Filing |
| 2022-05-13 4:00 pm Purchase | 2022-05-03 | 13G | Tarsus Pharmaceuticals, Inc. TARS | TANG CAPITAL PARTNERS LP | 2,091,753 7.900% | 2,091,753 (New Position) | Filing |